0
Special Feature |

Radiological Case of the Month FREE

[+] Author Affiliations

Section Editor: Beverly P. Wood, MD

More Author Information
Arch Pediatr Adolesc Med. 1998;152(10):1030. doi:.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: JUVENILE XANTHOGRANULOMA

Figure 1. Sagittal T1 magnetic resonance imaging scan of the chest wall mass.

Figure 2. Axial T1 magnetic resonance imaging scan of the chest wall mass.

Figure 3. Histological section from biopsy specimen of the chest wall mass shows a predominant population of large polygonal cells and a smaller number of admixed multinucleate Touton giant cells (hematoxylin-eosin, original magnification ×50).

The next day, an incisional biopsy was performed. Histological study of the mass showed a predominant population of large polygonal cells and a smaller number of admixed multinucleate giant cells (Figure 3). Both the mononuclear and multinuclear cells had a moderate to large amount of lightly eosinophilic cytoplasm. The nuclei in the mononuclear and multinucleate cells were slightly enlarged and irregular, but significant hyperchromasia was not present and nucleoli were inconspicuous. The mitotic rate was low at fewer than 2 mitoses per 10 high-power fields. The lesion infiltrated skeletal muscle. Stains for fungi and mycobacteria were negative. The mononuclear and multinucleate cells were strongly positive on a vimentin stain. Actin, desmin, S100, factor VIII, and cytokeratin stains all were negative.

Deep juvenile xanthogranuloma (JXG) is a rare fibrohistiocytic tumor and a less common form of xanthogranuloma (congenital xanthoma multiplex, nevoxanthoendothelioma), accounting for less than 5% of JXG. It occurs in newborns and infants, and is characterized by 1 or more cutaneous nodules, a self-limited course with spontaneous regression, and rare extracutaneous involvement. Neither the cutaneous nor the extracutaneous form of the disease is associated with underlying metabolic disease, lipid abnormality, or a familial incidence.1 Juvenile xanthogranuloma occurs in patients 0 to 5 years of age, and may also occur in adolescents and young adults.

Extracutaneous or deep JXG are reported in deep soft tissue and parenchymal organs. Expected sites of deep JXG include the eye, lung, epicardium, oral cavity, testes,2 central nervous system, liver/spleen, and muscle.3 The differential diagnosis of congenital, anterior chest wall tumors includes rhabdomyoblastoma, neuroblastoma, and primitive neuroectodermal tumor. Prognosis for deep JXG is excellent, as spontaneous regression does occur.4 A chromosomal analysis shows normal karyotype.5

Lesions can range in diameter from a few millimeters to several centimeters and are firm, well circumscribed, and vary from tan to yellow on the cut surface.37

Histological examination reveals sheets of well-differentiated histiocytes with little pleomorphism. The foamy cells have abundant cytoplasm and morphologically variable nuclei with finely dispersed chromatin. Multinucleated cells, including Touton giant cells, are typically present. Mixed inflammatory cell infiltrates may be present along the border of the lesion. Immunohistochemistry is characterized by the absence of 5-100 staining and variable presence of other histiocytic markers.7 The cortical thymocyte antigen, Cdla, is positive, suggesting a dermal "indeterminate" cell lineage.5 Ultrastructure examination shows histiocytes with irregular cell membrane and filiform cytoplasmic projections. Lipid bodies and myelin figures are present and Birbeck granules of Langerhans histiocytoses (histiocytosis X) are notably absent.

The pathogenesis of deep JXG is uncertain, and it is unresolved whether the lesion represents a true neoplasm or an unusual reaction. Both the clinical course of natural involution and the immunohistochemical profile lend support to the theory that JXG represents a benign histiocytic proliferation that is likely to be a reactive process.

Accepted for publication July 30, 1997.

Reprints: Butch M. Huston, MD, University of North Carolina Hospitals, Department of Pathology, 422 Brinkhous-Bullitt Bldg, CB 7525, Chapel Hill, NC 27599-7525.

Enzinger  FMWeiss  SW Benign fibrohistiocytic tumors. Enzinger  FMWeiss  SWeds.Soft Tissue Tumors St Louis, Mo Mosby–Year Book Inc1995;
DeGraaf  JHTimens  WTamminga  RYJMolenaar  WM Deep juvenile xanthogranuloma: a lesion related to dermal indeterminate cells. Hum Pathol. 1992;23905- 910
Freyer  DRKennedy  RBostrom  BCKohut  GDehner  LP Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;12227- 237
Janney  CGHurt  MASanta Cruz  DJ Deep juvenile xanthogranuloma: subcutaneous and intramuscular forms. Am J Surg Pathol. 1991;15150- 159
Isaacs  H Tumors. Gilbert-Barness  Eed.Potter's Pathology of the Fetus and Infant St Louis, Mo Mosby–Year Book Inc1997;1275
Dehner  LPKaye  V The skin. Stocker  JTDehner  LPeds.Pediatric Pathology Philadelphia, Pa JB Lippincott1992;1165- 1166
Sangueza  OPSalmon  JKWhite  CR  JrBeckstead  JH Juvenile xanthogranuloma: a clinical, histopathologic and immunohistochemical study. J Cutan Pathol. 1995;22327- 335

Tables

References

Enzinger  FMWeiss  SW Benign fibrohistiocytic tumors. Enzinger  FMWeiss  SWeds.Soft Tissue Tumors St Louis, Mo Mosby–Year Book Inc1995;
DeGraaf  JHTimens  WTamminga  RYJMolenaar  WM Deep juvenile xanthogranuloma: a lesion related to dermal indeterminate cells. Hum Pathol. 1992;23905- 910
Freyer  DRKennedy  RBostrom  BCKohut  GDehner  LP Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;12227- 237
Janney  CGHurt  MASanta Cruz  DJ Deep juvenile xanthogranuloma: subcutaneous and intramuscular forms. Am J Surg Pathol. 1991;15150- 159
Isaacs  H Tumors. Gilbert-Barness  Eed.Potter's Pathology of the Fetus and Infant St Louis, Mo Mosby–Year Book Inc1997;1275
Dehner  LPKaye  V The skin. Stocker  JTDehner  LPeds.Pediatric Pathology Philadelphia, Pa JB Lippincott1992;1165- 1166
Sangueza  OPSalmon  JKWhite  CR  JrBeckstead  JH Juvenile xanthogranuloma: a clinical, histopathologic and immunohistochemical study. J Cutan Pathol. 1995;22327- 335

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics